Profile
Kara J.
Stancell is currently the VP-Investor Relations & Corporate Communications at Clarus Therapeutics Holdings, Inc. She previously worked as the Executive Director-Investor Relations at Medicis Pharmaceutical Corp.
from 2010 to 2011 and as the VP-Investor Relations & Corporate Communications at Dermavant Sciences, Inc. from 2018 to 2021.
Kara Stancell active positions
| Companies | Position | Start |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Investor Relations Contact | - |
Former positions of Kara Stancell
| Companies | Position | End |
|---|---|---|
Dermavant Sciences, Inc.
 Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Investor Relations Contact | 2021-02-28 |
| MEDICIS PHARMACEUTICAL CORP | Public Communications Contact | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Medicis Pharmaceutical Corp.
 Medicis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Medicis Pharmaceutical Corp. develops and markets pharmaceutical products for dermatological usages. It offers a broad range of products addressing various conditions or aesthetic improvements, including facial wrinkles, glabellar lines, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, seborrheic dermatitis and cosmesis. The company was founded on July 28, 1988 and is headquartered in Phoenix, AZ. | Health Technology |
Dermavant Sciences, Inc.
Dermavant Sciences, Inc. BiotechnologyHealth Technology Part of Roivant Sciences Ltd., Dermavant Sciences, Inc. develops biological products. The private company is based in Raleigh, NC. Todd Zavodnick has been the CEO of the company since 2018. | Health Technology |
- Stock Market
- Insiders
- Kara Stancell